Treatment of non promyelocytic acute myeloid leukemia in elderly patients by low dose cytozar plus Arsenic trioxide
Phase 2
- Conditions
- Acute myeloid leukaemia.Acute myeloid leukaemia
- Registration Number
- IRCT138711061030N5
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Elderly patients with non promyelocytic AML, Performance status (ECOG) 3 or 4
Exclusion criteria:
Age <60 years old, AST or ALT more than ten times above normal, Serum billirubin above 5, Creatinine level>2
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response Rate. Timepoint: 1, 2, 6 month and one year after intervention. Method of measurement: Bone Marrow Aspiration and Biopsy and complete blood count.
- Secondary Outcome Measures
Name Time Method Overal Survival. Timepoint: One year after intervention. Method of measurement: Survey of patients.